Amylin gains 15% on expanded Byetta use, positive 3Q
21 October 2011
Donna Young
Please Login to read the full article.
21 October 2011
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- Amylin stock gains as more reports of potential buyers surface
- Amylin's Bydureon endures rejection; finally embraced by FDA
- NICE recommends Lilly's Bydureon, but which GLP-agonist will top UK market?
- Jury still out on benefits of glucose lowering treatments, says German HTA body
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
